BSF Enterprise Plc (BSFAF)
| Market Cap | 3.15M -34.2% |
| Revenue (ttm) | 71.03K -8.6% |
| Net Income | -1.50M |
| EPS | -0.01 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 141,000 |
| Average Volume | 28,684 |
| Open | 0.0300 |
| Previous Close | n/a |
| Day's Range | 0.0300 - 0.0300 |
| 52-Week Range | 0.0200 - 0.0822 |
| Beta | 3.18 |
| RSI | 29.57 |
| Earnings Date | Jan 30, 2026 |
About BSF Enterprise
BSF Enterprise Plc develops and commercializes cutting-edge tissue-engineered solutions. It offers lab-grown leather, cultivated meat, and corneal repair technologies. The company was incorporated in 2018 and is based in London, United Kingdom. [Read more]
Financial Performance
In fiscal year 2025, BSF Enterprise's revenue was 52,840, a decrease of -8.61% compared to the previous year's 57,821. Losses were -1.11 million, -33.41% less than in 2024.
Financial numbers in GBP Financial StatementsNews
BSF Enterprise PLC Announces Participation in The ThinkEquity Conference
London, United Kingdom--(Newsfile Corp. - October 5, 2023) - BSF Enterprise PLC (LSE: BSFA) (OTCQB: BSFAF), a company focused on unlocking the next generation of biotechnological solutions using cell-...
BSF Enterprise PLC Provides City-MixTM Bio-Pharmaceutical Update
LONDON, July 18, 2023 (GLOBE NEWSWIRE) -- BSF Enterprise PLC ("BSF" or the "Company") (LSE: BSFA), (OTCQB: BSFAF), a company focused on unlocking the next generation of biotechnological solutions usin...